Impressive the Eli Lilly has already completed a 1000 person trial of its RA drug in covid patients with positive results and FDA authorization on the horizon. And this is a drug that has a risk of thromboembolism in RA patients.

I wonder what's happened to RVX-208 and covid?

https://www.fiercepharma.com/pharma/eli-lilly-to-discuss-olumiant-emergency-authorization-fda-after-positive-covid-data?